Immunomodulatory Agents in Follicular Lymphoma.
Résumé
•
Immunomodulatory agents are now part of modern follicular lymphoma therapeutic management.
•
They offer a chemo-free strategy that provides a clinical benefit even for high-risk disease.
•
These strategies target tumor cells both directly and through microenvironment modifications.
•
We are still lacking biomarkers predicting efficacy of immunomodulatory agents.